Growth Metrics

Mannkind (MNKD) Accumulated Depreciation & Amortization (2010 - 2026)

Mannkind (MNKD) reported Accumulated Depreciation & Amortization of $115.8 million for Q1 2026, up 6.55% year-over-year from $108.7 million in Q1 2025, and up 1.65% on a QoQ basis from $113.9 million in Q4 2025.

Mannkind (MNKD) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $115.8 million in Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 6.55% year-over-year to $115.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.8 million (up 6.55% YoY) and the FY2025 annual result came in at $113.9 million, up 6.78% from the prior year.
  • Accumulated Depreciation & Amortization rose to $115.8 million in Q1 2026 per MNKD's latest filing, from $113.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $115.8 million in Q1 2026 and bottomed at $97.9 million in Q1 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $102.8 million (2024), against an average of $104.7 million.
  • The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization rose 0.92%; it then rose 6.78% in 2025.
  • Tracing MNKD's Accumulated Depreciation & Amortization over 5 years: stood at $98.6 million in 2022, then climbed by 3.02% to $101.5 million in 2023, then rose by 5.06% to $106.7 million in 2024, then advanced by 6.78% to $113.9 million in 2025, then increased by 1.65% to $115.8 million in 2026.
  • Per Business Quant, the three latest MNKD Accumulated Depreciation & Amortization figures stand at $115.8 million (Q1 2026), $113.9 million (Q4 2025), and $112.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 115.79 Mn
Mar 31, 2026 115.79 Mn
Dec 31, 2025 113.91 Mn
Dec 31, 2025 113.91 Mn
Sep 30, 2025 112.73 Mn
Sep 30, 2025 112.73 Mn
Jun 30, 2025 110.72 Mn
Jun 30, 2025 110.72 Mn
Mar 31, 2025 108.68 Mn
Mar 31, 2025 108.68 Mn
Dec 31, 2024 106.68 Mn
Dec 31, 2024 106.68 Mn
Sep 30, 2024 106.63 Mn
Sep 30, 2024 106.63 Mn
Jun 30, 2024 104.54 Mn
Jun 30, 2024 104.54 Mn
Mar 31, 2024 102.83 Mn
Mar 31, 2024 102.83 Mn
Dec 31, 2023 101.54 Mn
Dec 31, 2023 101.54 Mn
Sep 30, 2023 101.29 Mn
Sep 30, 2023 101.29 Mn
Jun 30, 2023 100.22 Mn
Jun 30, 2023 100.22 Mn
Mar 31, 2023 99.55 Mn
Mar 31, 2023 99.55 Mn
Dec 31, 2022 98.56 Mn
Dec 31, 2022 98.56 Mn
Sep 30, 2022 99.12 Mn
Sep 30, 2022 99.12 Mn
Jun 30, 2022 98.56 Mn
Jun 30, 2022 98.56 Mn
Mar 31, 2022 97.91 Mn
Mar 31, 2022 97.91 Mn
Dec 31, 2021 97.66 Mn
Dec 31, 2021 97.66 Mn
Sep 30, 2021 97.67 Mn
Sep 30, 2021 97.67 Mn
Jun 30, 2021 97.32 Mn
Jun 30, 2021 97.32 Mn
Mar 31, 2021 96.84 Mn
Mar 31, 2021 96.84 Mn
Dec 31, 2020 96.82 Mn
Dec 31, 2020 96.82 Mn
Sep 30, 2020 96.62 Mn
Sep 30, 2020 96.62 Mn
Jun 30, 2020 96.17 Mn
Jun 30, 2020 96.17 Mn
Mar 31, 2020 95.77 Mn
Mar 31, 2020 95.77 Mn
Dec 31, 2019 95.36 Mn
Dec 31, 2019 95.36 Mn
Sep 30, 2019 101.63 Mn
Sep 30, 2019 101.63 Mn
Jun 30, 2019 101.24 Mn
Jun 30, 2019 101.24 Mn
Mar 31, 2019 100.87 Mn
Mar 31, 2019 100.87 Mn
Dec 31, 2018 100.50 Mn
Dec 31, 2018 100.50 Mn
Sep 30, 2018 101.73 Mn
Sep 30, 2018 101.73 Mn
Jun 30, 2018 101.39 Mn
Jun 30, 2018 101.39 Mn
Mar 31, 2018 100.94 Mn
Mar 31, 2018 100.94 Mn
Dec 31, 2017 1.80 Mn
Dec 31, 2017 1.80 Mn
Sep 30, 2017 100.70 Mn
Sep 30, 2017 100.70 Mn
Jun 30, 2017 100.47 Mn
Jun 30, 2017 100.47 Mn
Mar 31, 2017 400,000.00
Mar 31, 2017 400,000.00
Dec 31, 2016 2.40 Mn
Dec 31, 2016 2.40 Mn
Sep 30, 2016 120.62 Mn
Sep 30, 2016 120.62 Mn
Jun 30, 2016 1.18 Mn
Jun 30, 2016 1.18 Mn
Mar 31, 2016 600,000.00
Mar 31, 2016 600,000.00
Dec 31, 2015 11.00 Mn
Dec 31, 2015 11.00 Mn
Sep 30, 2015 8.28 Mn
Sep 30, 2015 8.28 Mn
Jun 30, 2015 2.74 Mn
Jun 30, 2015 2.74 Mn
Mar 31, 2015 2.30 Mn
Mar 31, 2015 2.30 Mn
Dec 31, 2014 9.80 Mn
Dec 31, 2014 9.80 Mn
Sep 30, 2014 4.97 Mn
Sep 30, 2014 4.97 Mn
Jun 30, 2014 2.45 Mn
Jun 30, 2014 2.45 Mn
Mar 31, 2014 2.50 Mn
Mar 31, 2014 2.50 Mn
Dec 31, 2013 11.50 Mn
Dec 31, 2013 11.50 Mn
Sep 30, 2013 8.82 Mn
Sep 30, 2013 8.82 Mn
Jun 30, 2013 2.96 Mn
Jun 30, 2013 2.96 Mn
Mar 31, 2013 2.99 Mn
Mar 31, 2013 2.99 Mn
Dec 31, 2012 13.00 Mn
Dec 31, 2012 13.00 Mn
Sep 30, 2012 9.90 Mn
Sep 30, 2012 9.90 Mn
Jun 30, 2012 3.30 Mn
Jun 30, 2012 3.30 Mn
Mar 31, 2012 3.36 Mn
Mar 31, 2012 3.36 Mn
Dec 31, 2011 14.60 Mn
Dec 31, 2011 14.60 Mn
Sep 30, 2011 3.75 Mn
Sep 30, 2011 3.75 Mn
Jun 30, 2011 3.58 Mn
Jun 30, 2011 3.58 Mn
Dec 31, 2010 16.50 Mn
Dec 31, 2010 16.50 Mn